Related Experiment Video
Updated: Jul 4, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents
Martti Vaara1, John Fox, Günther Loidl
1Northern Antibiotics Ltd, Helsinki, Finland. martti.vaara@northernantibiotics.com
Abstract:
The lack of novel antibiotics against gram-negative bacteria has reinstated polymyxins as the drugs of last resort to treat serious infections caused by extremely multiresistant gram-negative organisms. However, polymyxins are nephrotoxic, and this feature may complicate therapy or even require its discontinuation. Like that of aminoglycosides, the nephrotoxicity of polymyxins might be related to the highly cationic nature of the molecule. Colistin and polymyxin B carry five positive charges. Here we show that novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. NAB739 has a cyclic peptide portion identical to that of polymyxin B, but in the linear portion of the peptide, it carries the threonyl-D-serinyl residue (no cationic charges) instead of the diaminobutyryl-threonyl-diaminobutyryl residue (two cationic charges). The MICs of NAB739 for 17 strains of Escherichia coli were identical, or very close, to those of polymyxin B. Furthermore, NAB739 was effective against other polymyxin-susceptible strains of Enterobacteriaceae and against Acinetobacter baumannii. At subinhibitory concentrations, it dramatically sensitized A. baumannii to low concentrations of antibiotics such as rifampin, clarithromycin, vancomycin, fusidic acid, and meropenem. NAB739 methanesulfonate was a prodrug analogous to colistin methanesulfonate. NAB740 was the most active derivative against Pseudomonas aeruginosa. NAB7061 (linear portion of the peptide, threonyl-aminobutyryl) lacked direct antibacterial activity but sensitized the targets to hydrophobic antibiotics by factors up to 2,000. The affinities of the NAB compounds for isolated rat kidney brush border membrane were significantly lower than that of polymyxin B.
Insights
Novel polymyxin derivatives with fewer positive charges show potent antibacterial activity against multidrug-resistant gram-negative bacteria. These compounds exhibit reduced nephrotoxicity, offering a promising alternative to existing last-resort antibiotics.
Area of Science:
- Microbiology
- Pharmacology
- Medicinal Chemistry
Background:
- Polymyxins are last-resort antibiotics for multidrug-resistant gram-negative infections.
- Polymyxin nephrotoxicity limits clinical use.
- Nephrotoxicity may stem from the highly cationic nature of polymyxins.
Purpose of the Study:
- To develop novel polymyxin derivatives with reduced positive charges.
- To evaluate the antibacterial efficacy and nephrotoxicity of these derivatives.
Main Methods:
- Synthesized polymyxin derivatives with three positive charges (e.g., NAB739).
- Assessed antibacterial activity (MICs) against Gram-negative bacteria, including Escherichia coli, Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa.
- Investigated synergistic effects with other antibiotics.
- Measured binding affinity to rat kidney brush border membrane.
Main Results:
- Novel derivatives (e.g., NAB739) exhibited potent activity against polymyxin-susceptible strains, comparable to polymyxin B.
- NAB739 sensitized Acinetobacter baumannii to various antibiotics at subinhibitory concentrations.
- NAB740 showed high activity against Pseudomonas aeruginosa.
- Derivatives demonstrated significantly lower affinities for kidney membranes compared to polymyxin B, suggesting reduced nephrotoxicity.
Conclusions:
- Reduced positive charge in polymyxin derivatives maintains antibacterial efficacy while potentially decreasing nephrotoxicity.
- These novel compounds represent promising candidates for treating challenging multidrug-resistant Gram-negative infections.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inhibitors of Bacterial Protein Synthesis
Antifungal Agents
Inhibitors of Bacterial DNA Synthesis
Antimicrobial Effectiveness

